Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
24.18
+1.62 (7.18%)
At close: Jul 30, 2026, 4:00 PM EDT
24.31
+0.13 (0.54%)
After-hours: Jul 30, 2026, 5:01 PM EDT

Adaptive Biotechnologies Revenue

Adaptive Biotechnologies had revenue of $71.55M in the quarter ending June 30, 2026, with 21.53% growth. This brings the company's revenue in the last twelve months to $308.08M, up 50.13% year-over-year. In the year 2025, Adaptive Biotechnologies had annual revenue of $276.98M with 54.77% growth.

Revenue (ttm)
$308.08M
Revenue Growth
+50.13%
P/S Ratio
11.86
Revenue / Employee
$493,720
Employees
624
Market Cap
3.85B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025276.98M98.02M54.77%
Dec 31, 2024178.96M8.68M5.10%
Dec 31, 2023170.28M-15.03M-8.11%
Dec 31, 2022185.31M30.96M20.06%
Dec 31, 2021154.34M55.96M56.88%
Dec 31, 202098.38M13.31M15.65%
Dec 31, 201985.07M29.41M52.83%
Dec 31, 201855.66M17.22M44.77%
Dec 31, 201738.45M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
RadNet2.14B
Qiagen2.10B
Sotera Health Company1.19B
NeoGenomics766.30M
Veracyte541.74M
GeneDx Holdings442.68M
CareDx412.82M
Twist Bioscience409.48M
Revenue Rankings